Reversal of topotecan resistance by PAK 200 S, a new dihydropyridine analogue, in human ovarian and breast cancer cells that overexpress p 170. - Vanhoefer,U.; Hilger,R.; Schleucher,N. (Proc. Am. Assoc. Cancer Res., 1997)